Maarga Mind Care has launched an Integrated Maternal Mental Health Programme along with Maarga Divasa, an integrated day care programme aimed at supporting mothers through the emotional and psychological challenges that often come with pregnan...
India's pharma exports to the US are expected to stay muted amid pricing pressure, policy uncertainty, and inventory correction in generics, with experts flagging structural shifts in demand and tighter procurement patterns.
TheraNym Biologics, a contract manufacturing arm of Aurobindo Pharma, has inaugurated a state-of-the-art biologics manufacturing facility in Telangana with an investment of ?1,200 crore, marking a significant expansion in India’s advanced pharma...
Lupin Limited and Natco Pharma have received US FDA approval for Eribulin Mesylate Injection, expanding their oncology portfolio and strengthening access to generic cancer treatments in the United States market.
Johnson & Johnson India has introduced its advanced Pulsed Field Ablation technology in India, marking a significant development in the country’s cardiac care landscape. The launch is expected to enhance treatment options for patients sufferin...
Akums secures European CEP approval for Cefpodoxime Proxetil, strengthening its global regulatory standing and expanding access to regulated markets, reinforcing India’s growing role in compliant API manufacturing and pharma supply chains.
Delhi High Court asks CDSCO to review Zydus semaglutide approval, raising concerns over dosing safety and drug delivery design, with wider implications for India’s fast-growing GLP-1 and diabetes drug market.
Intracin Pharma, APVMA approval, and Australia expansion mark a major milestone for the Indian veterinary pharmaceutical company as it prepares to supply veterinary medicines in Australia, one of the world’s most tightly regulated animal healthca...
Alkem Laboratories has introduced single-shot pre-filled syringes of semaglutide in India, expanding delivery options for obesity and Type 2 diabetes treatment amid growing competition in the metabolic care market.
Pfizer has launched its bispecific antibody therapy elranatamab in India, marking a significant step forward in the treatment landscape for patients with relapsed or refractory multiple myeloma. The launch reinforces the company’s commitm...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")